Quest Diagnostics director granted 1,142 shares
Quest Diagnostics director Tracey Doi received an equity award tied to her board service.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Quest Diagnostics director Tracey Doi received an equity award tied to her board service. She acquired 1,142 shares of Common Stock as a grant with no cash price per share, described in the footnotes as an award of restricted stock units. After this award and related dividend reinvestments, she directly holds 7,748 shares.
Insider Trade Summary
Grant/Award: 1,142 shares
Grant/Award
1 txn
Insider
Doi Tracey
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,142 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 7,748 shares (Direct)
Footnotes (2)
- F1. Represents an award of restricted stock units.
- F2. The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
Key Figures
Equity award size: 1,142 shares
Grant price per share: $0.00 per share
Shares owned after grant: 7,748 shares
3 metrics
Equity award size
1,142 shares
Grant of Common Stock on 2026-05-20
Grant price per share
$0.00 per share
Compensation-related grant, not open-market purchase
Shares owned after grant
7,748 shares
Direct holdings following award and dividend reinvestment
Key Terms
restricted stock units, dividend reinvestment, Deferred Compensation Plan for Directors
3 terms
restricted stock units financial
"Represents an award of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend reinvestment financial
"includes shares acquired via dividend reinvestment since the date of reporting person's last filing"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
Deferred Compensation Plan for Directors financial
"pursuant to the Amended and Restated Deferred Compensation Plan for Directors."
A deferred compensation plan for directors is an arrangement that lets board members postpone receiving part of their pay until a later date—often retirement or a set future time—so the money can grow or be paid under specified conditions. Think of it like directing a portion of your paycheck into a locked savings account that pays out later; investors care because it creates future cash or stock obligations, signals how the company motivates and retains leadership, and can affect shareholder value through timing of payouts or potential dilution.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Quest Diagnostics (DGX) director Tracey Doi report?
Director Tracey Doi reported receiving an equity award from Quest Diagnostics. The Form 4 shows she acquired 1,142 shares of Common Stock as a grant, described as restricted stock units, increasing her direct holdings to 7,748 shares after the transaction and related dividend reinvestments.
What are Tracey Doi’s Quest Diagnostics (DGX) holdings after this grant?
After this grant, Tracey Doi directly holds 7,748 Quest Diagnostics shares. This figure includes the 1,142-share award and shares accumulated through dividend reinvestment since her prior Form 4, as noted in the filing’s footnotes describing the deferred compensation plan for directors.
Was the Quest Diagnostics (DGX) insider transaction an open-market buy or a grant?
The Quest Diagnostics insider transaction was a grant, not an open-market buy. The Form 4 uses transaction code A, with a description of grant, award, or other acquisition, and a price per share of $0.00, indicating compensation-related restricted stock units rather than a market purchase.
What do the Quest Diagnostics (DGX) Form 4 footnotes say about the award?
The footnotes state the transaction represents an award of restricted stock units. They also explain the reported total includes shares acquired via dividend reinvestment under the Amended and Restated Deferred Compensation Plan for Directors since Tracey Doi’s last Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
